XML 58 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 12 - Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2021
Notes Tables  
Schedule of Net Funded Status [Table Text Block]
  

December 31,

 
  

2021

  

2020

 

(Amounts in thousands)

        

Beginning balance

 $12,579  $11,312 

Effect of curtailment

  289    

Service cost

  352   310 

Interest cost

  315   355 

Actuarial (gain) loss

  (1,472)  1,217 

Benefits paid

  (605)  (615)

Ending balance

 $11,458  $12,579 
Schedule of Net Benefit Costs [Table Text Block]
  

Year Ended December 31,

  
  

2021

  

2020

  

2019

 

Income Statement Location

(Amounts in thousands)

             

Service cost

 $352  $310  $320 

Salaries and employee benefits

Interest cost

  315   355   404 

Other expense

Effect of curtailment

  289       

Salaries and employee benefits

Amortization of prior service cost

  124   201   257 

Other expense

Amortization of losses

  264   186   20 

Other expense

Net periodic cost

 $1,344  $1,052  $1,001  
              

Assumed discount rate

  2.88%  2.53%  3.10% 
Schedule of Expected Benefit Payments [Table Text Block]

(Amounts in thousands)

    

2022

 $685 

2023

  684 

2024

  734 

2025

  729 

2026

  831 

2027 through 2031

  3,669 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Year Ended December 31,

 
  

2021

  

2020

  

2019

 

(Amounts in thousands)

            

Pre-tax compensation expense

 $1,282  $1,643  $1,481 

Excess tax (benefit) expense

  (633)  202   (340)
Share-based Payment Arrangement, Option, Activity [Table Text Block]

(Amounts in thousands, except share and per share data)

 

Option Shares

  

Weighted Average Exercise Price Per Share

  

Weighted Average Remaining Contractual Term (Years)

  

Aggregate Intrinsic Value

 
                 

Outstanding, January 1, 2021

  114,279  $19.56         

Granted

  131,198   33.00         

Exercised

  (39,995)  13.44         

Canceled/Expired

  (604)  24.72         

Outstanding, December 31, 2021

  204,878  $29.35   4.99  $834 

Exercisable, December 31, 2021

  73,680  $22.84   5.42  $779 
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
  

Shares

  

Weighted Average Grant-Date Fair Value

 
         

Nonvested, January 1, 2021

  84,915  $25.31 

Granted

      

Vested

  (37,497)  26.93 

Canceled

  (1,762)  23.85 

Nonvested, December 31, 2021

  45,656  $24.03